Zhenyu Li

3.2k total citations
73 papers, 1.5k citations indexed

About

Zhenyu Li is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Zhenyu Li has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 22 papers in Hematology and 17 papers in Molecular Biology. Recurrent topics in Zhenyu Li's work include CAR-T cell therapy research (22 papers), Multiple Myeloma Research and Treatments (9 papers) and Immune Cell Function and Interaction (7 papers). Zhenyu Li is often cited by papers focused on CAR-T cell therapy research (22 papers), Multiple Myeloma Research and Treatments (9 papers) and Immune Cell Function and Interaction (7 papers). Zhenyu Li collaborates with scholars based in China, United States and Panama. Zhenyu Li's co-authors include Kailin Xu, Jiang Cao, Wei Zhao, Yuhui Yang, Xiaoyun Zhang, Tao Liu, Zihan Xia, Hong Ma, Ji Cheng and Yanxia Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Zhenyu Li

63 papers receiving 1.4k citations

Peers

Zhenyu Li
Kate McArthur Australia
Galina A. Gusarova United States
Xu D China
Monica V. Talor United States
Zhenyu Li
Citations per year, relative to Zhenyu Li Zhenyu Li (= 1×) peers Zhengguo Zhang

Countries citing papers authored by Zhenyu Li

Since Specialization
Citations

This map shows the geographic impact of Zhenyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyu Li more than expected).

Fields of papers citing papers by Zhenyu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyu Li. The network helps show where Zhenyu Li may publish in the future.

Co-authorship network of co-authors of Zhenyu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyu Li. A scholar is included among the top collaborators of Zhenyu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyu Li. Zhenyu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yanxia, Aoyang Yü, Yu Rao, et al.. (2025). Single-cell transcriptomics identifies PDIA4 as a marker of progression and therapeutic vulnerability in multiple myeloma. Journal of Translational Medicine. 23(1). 1136–1136.
2.
Li, Hujun, Huanxin Zhang, Hai Cheng, et al.. (2025). Effect of metachronous primary and secondary solid cancers in patients with multiple myeloma: a retrospective study from a single-center. Frontiers in Immunology. 16. 1516471–1516471.
3.
Wang, Yiwen, Yihan Chen, Zhenyu Li, et al.. (2025). Salicylic Acid-Conjugated Mesoporous Silica Nanoparticles Elicit Remarkable Resistance to Rice Sheath Blight. Agronomy. 15(4). 874–874.
5.
Wang, Xiangmin, Qing Zhang, Hongyuan Zhou, et al.. (2024). Impact of tocilizumab on anti‐CD19 chimeric antigen receptor T‐cell therapy in B‐cell acute lymphoblastic leukemia. Cancer. 130(15). 2660–2669. 3 indexed citations
6.
Li, Yingying, Huimin Jiang, Xinyi Li, et al.. (2024). Platelet-Specific Deletion of TGF-β1 Impairs Septic Thrombosis in Mice—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 45(1). 136–143. 3 indexed citations
7.
Li, Sen, Pengfei Ma, Junli Zhang, et al.. (2024). Clinicopathological features and prognoses in younger and older patients with mismatch repair defects colorectal cancer: a retrospective comparative cohort study. Journal of Gastrointestinal Oncology. 15(1). 260–270. 2 indexed citations
8.
Ren, Jingwen, Pengfei Li, Jie Luo, et al.. (2023). Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries. International Journal of Infectious Diseases. 132. 9–16. 5 indexed citations
9.
Chen, Huimin, et al.. (2023). CD86 Is Associated with Immune Infiltration and Immunotherapy Signatures in AML and Promotes Its Progression. Journal of Oncology. 2023. 1–19. 16 indexed citations
10.
Sang, Wei, Xiangmin Wang, Tianci Li, et al.. (2022). Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma. Frontiers in Immunology. 13. 858021–858021. 37 indexed citations
11.
Zhao, Yingchao, et al.. (2022). Novel germline mutation in lung cancer pedigrees establishes BCAR1 as a human cancer susceptibility gene: a case report. Annals of Translational Medicine. 10(4). 237–237. 1 indexed citations
12.
Hong, Fei, Ming Shi, Jiang Cao, et al.. (2021). Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia. Journal of Cellular and Molecular Medicine. 25(24). 11063–11074. 23 indexed citations
13.
Qi, Kunming, Zhiling Yan, Hai Cheng, et al.. (2021). An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective Study. Frontiers in Oncology. 11. 691064–691064. 26 indexed citations
14.
Li, Zhenyu, Xiaolin Xu, Meiling Yang, et al.. (2020). Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic. Aging. 12(23). 24453–24461. 11 indexed citations
15.
Wu, Qingyun, Mengmeng Ma, Sen Zhang, et al.. (2018). Loss of K607 and E877 interaction is a key reason for JAK2 K607N mutation caused acute myeloid leukemia. International Journal of Biological Macromolecules. 124. 1123–1131. 7 indexed citations
16.
Li, Zhenyu, et al.. (2017). Laparoscopic combined with thoracoscopic resection in hepatocellular carcinoma of hepatic VII and VIII segments. Zhonghua gan-dan waike zazhi. 23(8). 555–556.
17.
Li, Zhenyu, et al.. (2016). Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis. Journal of Cancer Research and Therapeutics. 12(2). 1040–1044. 9 indexed citations
18.
Zhao, Kai, Lingling Yin, Chong Chen, et al.. (2014). Interleukin-22 Aggravates Murine Acute Graft-Versus-Host Disease by Expanding Effector T Cell and Reducing Regulatory T Cell. Journal of Interferon & Cytokine Research. 34(9). 707–715. 28 indexed citations
19.
Li, Yanjie, Depeng Li, Zhiling Yan, et al.. (2014). Potential relationship and clinical significance of miRNAs and Th17 cytokines in patients with multiple myeloma. Leukemia Research. 38(9). 1130–1135. 12 indexed citations
20.
Chen, Jiao, Yuxin Hu, Zhenyu Li, et al.. (2014). Sirt1 Deletion Leads to Enhanced Inflammation and Aggravates Endotoxin-Induced Acute Kidney Injury. PLoS ONE. 9(6). e98909–e98909. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026